- Residency - Einstein Medical Center (2011-2014), Internal Medicine
- Fellowship - Sidney Kimmel Medical College (2014-2017), Hematology Oncology
- Medical School - Medical College University of Kerala (2000-2007)
Praveen Ramakrishnan, M.D.
- Internal Medicine - Hematology/Oncology
- Lymphoma Treatment
- Cellular Therapy
Praveen Ramakrishnan, M.D., M.S., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. Dr. Ramakrishnan is originally from India and received his initial medical training at the Medical College, University of Kerala, India. He then completed a residency in internal medicine from the prestigious Jawaharlal Institute of Medical Education and Research (JIPMER), Puducherry, India. Drawn by the opportunity for the integration of clinical medicine, hematologic malignancies, and stem cell transplantation, he completed his hematology and medical oncology fellowship at the Thomas Jefferson University Hospital, Philadelphia, PA. He also earned a Masters of Science in Human Investigation and Pharmacology through the NIH K30 Training Program.
Dr. Ramakrishnan specializes in taking care of patients with aggressive lymphomas and other complex hemato-lymphoid malignancies. His research focuses on developing targeted and cellular therapies for treating patients with lymphomas. In his clinical practice, patients are managed with state-of-the-art therapies with a specific focus on personalized innovative clinical trials. Along with his colleagues in neurosurgery and radiation oncology, he is leading an effort to build a regional program of excellence dedicated to taking care of patients with CNS lymphomas at UT Southwestern. He is a strong proponent of practicing medicine centered around the individual patient and their families.
Dr. Ramakrishnan’s interests outside of medicine include reading, watching movies, travel, and quizzing. During his residency, he was a three-time national champion at the ACP Doctor's Dilemma competition.
- American Medical Association (2011), Member
- American College of Physicians (2011), Member
- American Society for Clinical Oncology (2013), Member
- American Society for Hematology (2014), Member
- Indo-American Cancer Association (2015), Member
- American Society for Blood and Marrow Transplantation (2015), Member
- American Association for the Advancement of Science (2016), Member
- American Association for Cancer Research (2016), Member
- Texas Medical Association (2017), Member
- Dallas County Medical Society (2017), Member
- Dr. Chandrasekar Memorial Gold Medal - Best Outgoing Post Graduate, Internal Medicine 2010, Jawaharlal Institute of Postgraduate Medical Education and Research, India
- Certificate of Merit for First Prize 2012, ACP National Doctors Dilemma Competition (Medical Jeopardy) New Orleans, LA
- Sonia Stupniker, M.D. Award for Outstanding Achievement in Scholarly Activity 2014, Albert Einstein Medial Center Convocation, Philadelphia, PA
- Gold Medal, Best Research Dissertation 2010, Jawaharlal Institute of Postgraduate Medical Education and Research, India
- Gold Medals in Obstetrics and Gynecology, Physiology, and Biophysics 2005, Government Medical College, University of Kerala, India
- Gold Medals in Cardiology, Neurology, and Internal Medicine 2010, Jawaharlal Institute of Postgraduate Medical Education and Research, India
An evaluation of zanubrutinib, a BTK inhibitor, for the treatment of chronic lymphocytic leukemia.
Geethakumari PR, Awan F. Expert Rev Hematol 2020 13 10 1039-1046
A Radiomic Machine Learning Model to Predict Treatment Response to Methotrexate and Survival Outcomes in Primary Central Nervous System Lymphoma
Ali O, Nalawade S, Xi Y, Wagner B, Mazal A, Ahlers S, Rizvi S, Awan F, Kumar K, Desai NB, Maldjian JA, Pinho M, Ramakrishnan Geethakumari P Blood 2020 136 Supplement 1 29-30
Comparison of Demographics, Treatment Patterns and Outcomes among Primary Central Nervous System Lymphoma (PCNSL) Patients Treated at a Safety-Net Hospital versus a Tertiary Academic Institution within the same Healthcare System
Patel A, Ali O, Kainthla R, Rizvi S, Awan F, Desai NB, Timmerman R, Kumar K, Ramakrishnan Geethakumari P Blood 2020 136 Supplement 1 11-12
CAR T-cell Therapy in Relapsed/ Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL): A ?Real-World? Analysis of Patterns of Failure and Role of Bridging Therapy
Ravella R, Ramakrishnan Geethakumari P, Kumar K, et al. Blood 2020 136 Supplement 1 22-23
Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation.
Jagadeesh D, Majhail NS, He Y, Ahn KW, Litovich C, Ahmed S, Aljurf M, Bacher U, Badawy SM, Bejanyan N, Cairo M, Cerny J, Epperla N, Farhadfar N, Freytes CO, Gale RP, Haverkos B, Hossain N, Inwards D, Kamble RT, Kenkre VP, Lazarus HM, Lazaryan A, Lekakis L, Mei M, Murthy HS, Mussetti A, Nathan S, Nishihori T, Olsson RF, Ramakrishnan Geethakumari P, Savani BN, Yared JA, Fenske TS, Kharfan-Dabaja MA, Sureda A, Hamadani M, Cancer 2020 Feb
Breast Implant-associated Plasmablastic Lymphoma: A Case Report and Discussion of the Literature.
Geethakumari PR, Markantonis J, Shah JL, Alsuwaidan A, Shahab I, Chen W, Jaso JM, Clinical lymphoma, myeloma & leukemia 2019 Jun
Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a CIBMTR analysis
Epperla N, Ahn KW, Litovich C, Ramakrishnan P, Fenske TS, Hamadani M, et al. Journal of Hematology & Oncology 2019 12
MYC Partner Matters: MYC-IGH is Associated with Inferior Survival in De Novo High-Grade B-cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements.
Chaudhry R, Alsuwaidan A, Ramakrishnan Geethakumari P, Chen et al. Laboratory Investigation - Nature 2019 99 March 1
Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure.
Smith SM, Godfrey J, Ahn KW, DiGilio A, Ahmed S, Agrawal V, Bachanova V, Bacher U, Bashey A, Bolaños-Meade J, Cairo M, Chen A, Chhabra S, Copelan E, Dahi PB, Aljurf M, Farooq U, Ganguly S, Hertzberg M, Holmberg L, Inwards D, Kanate AS, Karmali R, Kenkre VP, Kharfan-Dabaja MA, Klein A, Lazarus HM, Mei M, Mussetti A, Nishihori T, Ramakrishnan Geethakumari P, Saad A, Savani BN, Schouten HC, Shah N, Urbano-Ispizua A, Vij R, Vose J, Sureda A, Hamadani M Cancer 2018 Apr
Higher rates of relapse in maternal recipients of haploidentical hematopoietic stem cell transplantation from adult offspring donors for AML and myelodysplastic syndrome.
Geethakumari PR, Leiby B, Nair R, Alpdogan SO, Carabasi M, Filicko-O'Hara J, Gaballa S, Kasner M, Klumpp T, Martinez-Outschoorn U, Palmisiano N, Wagner JL, Porcu P, Flomenberg N, Grosso D, Bone marrow transplantation 2017 10 52 10 1465-1467
PARP Inhibitors in Prostate Cancer.
Ramakrishnan Geethakumari P, Schiewer MJ, Knudsen KE, Kelly WK Current treatment options in oncology 2017 Jun 18 6 37
Complement inhibition with eculizumab for thrombotic microangiopathy rescues a living-donor kidney transplant in a patient with antiphospholipid antibody syndrome.
Geethakumari PR, Mille P, Gulati R, Nagalla S Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2017 Mar
The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer.
Chae YK, Gagliato Dde M, Pai SG, Carneiro B, Mohindra N, Giles FJ, Ramakrishnan-Geethakumari P, Sohn J, Liu S, Chen H, Ueno N, Hortobagyi G, Gonzalez-Angulo AM PloS one 2016 11 4 e0152585
Extramedullary B lymphoblastic leukemia/lymphoma (B-ALL/B-LBL): a diagnostic challenge.
Geethakumari PR, Hoffmann MS, Pemmaraju N, Hu S, Jorgensen JL, O'Brien S, Daver N Clinical lymphoma, myeloma & leukemia 2014 Aug 14 4 e115-8
Increasing colon cancer screening in primary care among African Americans.
Myers RE, Sifri R, Daskalakis C, DiCarlo M, Geethakumari PR, Cocroft J, Minnick C, Brisbon N, Vernon SW Journal of the National Cancer Institute 2014 Dec 106 12
Genetic analysis of OCT1 gene polymorphisms in an Indian population.
Umamaheswaran G, Praveen RG, Arunkumar AS, Das AK, Shewade DG, Adithan C Indian journal of human genetics 2011 Sep 17 3 164-8
Association of Reduced-Intensity Conditioning Regimens With Overall Survival Among Patients With Non-Hodgkin Lymphoma Undergoing Allogeneic Transplant.
Ghosh N, Ahmed S, Ahn KW, Ramakrishnan P, et al. JAMA Oncology 2020 7 6 1011-1018
Evaluation of SARS-CoV-2 Serological Testing in Patients with Multiple Myeloma and Other Hematologic Malignancies on Monoclonal Antibody Therapies.
Mahimainathan L, Narasimhan M, Corchado R, Patel H, Kansagra A, Devaraj S, Ramakrishnan Geethakumari P, Muthukumar A. Diagnostics 2020 12 10 992
- An evaluation of zanubrutinib, a BTK inhibitor, for the treatment of chronic lymphocytic leukemia.
- Lymphoma Research
- Targeted Therapy
- Cellular Therapy
- Stem Cell Transplantation
- Hematologic Malignancies
- Lymphoma Treatment
- Cellular Therapy
- Targeted Therapy
- Bone Marrow Transplant
- Rare and Orphan Hematologic Disorders
- Histiocytic Disorders
- Malignant Hematology
Showing 1 locations
Dallas, Texas 75390 214-645-4673